INTRODUCTION
The cholesterol esterifying enzyme, lecithin-cholesterol acyltransferase (LCAT; EC 2.3.1.43), is secreted by the liver into the circulation where it catalyses the transfer of a fatty acid from the C-2 position of lecithin to the 3,/-hydroxyl group of cholesterol [1] . The reaction occurs in the surface of high-density lipoprotein particles, using its major apolipoprotein, apoA-I, as a cofactor [2] , and plays an important role in the net transport ofcholesterol from peripheral cells to the liver for excretion, a process termed reverse cholesterol transport [3, 4] . Familial or secondary (hepatic disease) LCAT deficiency results in lipoproteins with gross structural and compositional abnormalities; these appear to induce a variety of cellular dysfunctions, either by altering membrane lipid composition or by direct apolipoproteinmediated effects [5, 6] .
Cloning of LCAT cDNA and genomic DNA has shown that the gene consists of six exons encoding a protein of 416 amino acids (47090 kDa) [7, 8] . The primary structure of human LCAT has been determined indirectly by sequencing LCAT cDNA [7] and directly by amino acid sequencing [9] . The active catalytic site has been identified as by the use of specific chemical modifications, by sequence comparison with other lipases and by site-directed mutagenesis [10] . Nevertheless, the mechanism remains controversial; the proposed formation of an obligatory LCAT-S-acyl intermediate utilizing one or both of the free cysteine residues at positions 31 and 184 [10] has been challenged by site-directed mutagenesis studies [11, 12] .
Mature, circulating LCAT is a glycoprotein with an apparent molecular mass of about 68 000 kDa and a carbohydrate content of 25 % by weight, of which up to 7% is sialic acid [13] . The type AcNPV infections. Enzymically active recombinant LCAT (rLCAT), sensitive to sulphydryl reagents, was secreted in the late phase of infection (36-48 h) but was absent with wild-type infections. The secreted protein had an apparent molecular mass of 53 kDa by SDS/PAGE, lower than that of native plasma LCAT; it was susceptible to endoglycosidase H digestion and was bound by concanavalin A, suggesting that precursor highmannose N-glycan chains had not undergone full maturation to complex types. Pretreatment of the cells with tunicamycin to inhibit the first step of N-glycosylation led to intracellular accumulation of immature rLCAT ( 46-48 kDa) and a marked reduction in enzyme secreted. We conclude that the baculovirus gene-expression system will permit production of biologically active normal and mutant forms of LCAT protein.
polypeptide backbone of LCAT contains four N-glycosylation sites at positions 20, 84, 272 and 384, as indicated by the consensus sequence Asn-X-Ser/Thr, and these all appear to be used [9, 14] . The role of this carbohydrate moiety has been investigated by use of glycosidases [15, 16] and, more recently, by site-directed mutagenesis [14, [17] [18] [19] . However, while it is clear that the presence of a glycan chain at each site can influence intracellular processing, secretion and/or catalytic functioning of LCAT, the inconsistencies between the various reports do not permit definitive conclusions. This is not entirely unexpected: use of glycosylation inhibitors might influence the functioning of other proteins involved in LCAT processing, the final structure of the glycan chain produced might be dependent on the cell type transfected and there might be effects due to the amino acid substitution itself. There could also be additional problems of interpretation associated with a secreted LCAT enzyme of verylow-specific activity or which is produced only transiently [10] .
Clearly, more detailed studies of LCAT structure-function and its (patho)physiological role in lipoprotein metabolism would benefit from the availability of significant amounts of wild-type and mutant enzyme, particularly as transient expression of recombinant LCAT (rLCAT) has inherent limitations and isolation of the plasma enzyme is labour-intensive or impractical.
As an alternative approach, we have examined the feasibility of producing rLCAT in cultured insect cells using a commercial baculovirus expression system. Potentially, this should not only allow high-level expression through the use of extremely efficient polyhedrin-promoter based vectors, but also circumvent certain difficulties associated with transient expression in mammalian cells or with maintaining a stably transfected cell line. We found that a nuclear polyhedrosis-based virus was able to drive the LCAT cONA cloning Into pVL 1392
The baculovirus plasmid pVL1392 containing a multiple cloning site was digested with EcoRI and BamHI. Full-length human LCAT cDNA (1.42 kb) in pUC 19 plasmid was excised with EcoRI and BamHI to produce a cDNA clone extending from 32 bases before the ATG start codon to 3 bases after the last triplet codon; this was then ligated to the unique EcoRI/BamHI site of pVL1392 with T4 ligase.
Culture and transfectlon of High 5 cells
The insect cell line, termed High 5 (Trichoplusia ni egg cells) was grown as adherent monolayers in TC-100 medium supplemented with 5 % (v/v) heat-inactivated fetal bovine serum, 5 mM Lglutamine, penicillin (100 U/ml) and gentamycin (0.03 mg/ml) at 27 'C. Subconfluent cells in a 35 mm dish were cotransfected with the baculovirus plasmid containing LCAT cDNA (pVL 1392.LCAT) (2,ug) and linearized baculogold DNA (0.1,ug) using lipofectin (15 ,ug) in serum-free medium for 4 h at 27 'C. Incubation was continued with fresh growth medium to allow secretion of extracellular recombinant virus [Autographa californica LCAT (AcLCAT)]. This medium was stored at 4 'C and was used for subsequent inoculations of other flasks. After three amplification rounds of the stock virus, the culture medium of infected cells was examined for secreted rLCAT protein.
Measurement of LCAT activity LCAT activity was determined in appropriate aliquots of culture media using an exogenous proteoliposome substrate of [14C]cholesterol, egg lecithin and apoA-I [20] , as described previously [21] . Incubation time was 1 [22] Endoglycosidase H digestion After immunoprecipitation, the protein A-Sepharose beads were washed twice with water and were denatured by boiling for 5 min in 18 ,u of water. The samples were mixed with 2 M sodium acetate, pH 6.0 (2 ,ul), and incubated overnight at 37 'C with 1 4ul of endoglycosidase H (1 U/ml).
RESULTS
Expression of human LCAT A 1.42 kb fragment from pUC19.LCAT, containing the complete coding sequence of LCAT, was inserted into the baculovirus vector pVL 1392 placing it under the control of a baculovirus polyhedrin promoter [23] [24] [25] [26] . This transfer vector, pVL 1392.LCAT, was used to generate recombinant virus, containing LCAT cDNA in place of polyhedrin, by homologous recombination after cotransfection of the High 5 cells with linear baculogold DNA. Successful infections were accompanied by a morphological change, from fibroblast-like to rounded cells, but polyhedrin occlusion bodies were seen only with wild-type [Autographa californica nuclear polyhedrosis virus (AcNPV)] infections and not with the recombinant AcLCAT virus ( Figure  1) . As recommended by the manufacturers, secreted extracellular AcLCAT virus was amplified several times and stock aliquots were used for infection of fresh subconfluent monolayers of cells. Little change in infectivity was noted after three amplification rounds and at this stage the virus retained infectivity at dilutions of 10-7.
Assay of the culture media post-infection showed that LCAT activity was detectable after 16 h and that maximum activity was Flasks of subconfluent cells were infected as described in Figure 1 and aliquots of medium (25 ,ul) removed at various time intervals for measurement of LCAT. Because no commercial mass assay is available for LCAT, the results are expressed as enzymic activities (nmol of free cholesterol esterified/h per ml of culture media) as described in the Experimental section for cells infected with AcNPV (U) and with AcLCAT (0). Other infections gave similar time courses for secretion of LCAT activity with the peak occurring at 36-48 h.
reached at about 40 h (Figure 2 ). Most infections produced peak activities in the range 6-15 nmol of cholesteryl ester formed/h per ml of culture medium, as measured by the proteoliposome exogenous substrate method. This is somewhat less than that secreted by stably transformed baby hamster kidney cells (18 nmol/h per ml after a 24 h incubation period) corresponding, by analogy with this cell line and assuming the same specific activity [14] , to a concentration of 1.5-3.5 gg of rLCAT per ml. However, optimizing the yield was not an aim of the present study; this is currently being carried out by inoculating stirred suspension cultures with high-titred virus stocks cloned by plaque assays and an eventual output -at least 10-fold higher is anticipated.
Conversion of cholesterol to cholesteryl ester by the culture medium was totally inhibited by addition of 1.4 mM 5,5'- dithiobis(2-nitrobenzoic acid), a sulphydryl reagent known to abolish plasma LCAT activity at this concentration (results not shown). Unexpectedly, extending the post-infection period caused a rapid decline in LCAT activity (Figure 2 ). The reasons for this were not investigated further but may reflect the release of harmful cellular constituents as the cells died or the known instability of the pure enzyme to buffers of even modest ionic strength [27] . No activity was detected in culture media of uninfected cells or in cells infected with wild-type virus ( Figure   2 ). [12, 18, 19] and human embryonic kidney-293 [30] , all produce recombinant enzymes with a molecular mass indistinguishable from that of plasma LCAT ( -68 kDa) by SDS/PAGE. This suggests that these different vertebrate expression systems secrete fully glycosylated LCAT with mainly complex-type oligosaccharides, although there is some evidence for the additional presence of high-mannose chains [16] . Nevertheless, despite having a different type of glycosylation pattern, the rLCAT secreted by insect cells was catalytically active. This is consistent with findings in transfected Chinese hamster ovary cells in which inhibitors of high-mannose residue processing had little effect on either the secretion rate or catalytic activity of the rLCAT produced [16] .
Immunopreciptation of [35SJLCAT
Baculoviruses have become an increasingly important geneexpression system for obtaining large amounts of eukaryotic proteins, the insect cell providing a suitable environment for requisite post-translational modifications, folding and assembly such that most proteins produced are biologically and immunologically active [23, 26] . Our present demonstration that catalytically active rLCAT can be produced by this system has several implications. The technique is particularly amenable to scaling-up, either through the use of stirred suspension cultures as indicated earlier or by larval production systems [24, 25] , such that sufficient quantities ofhomogeneous LCAT could be isolated for the development of routine immunological assays. This might encompass the generation of murine monoclonal antibodies; so far this has proved elusive, presumably because of the close sequence homology between human and murine LCAT [31] , but conceivably may be feasible with our rLCAT if minor changes in secondary and tertiary structure are induced by the anomalous N-linked glycans. It is also possible that the lower carbohydrate content of insect cell-derived rLCAT ( -11 % versus 25 % in plasma or mammalian cell-produced LCAT) may be advantageous to crystal formation, thereby permitting determination of its three-dimensional structure. Additionally, isomorphic proteins for X-ray crystallographic analysis could be generated by replacing methionine in the culture media with the normally toxic analogue, selenomethionine, during the late phase of infection [32] . Finally, recent advances in the construction and utilization of baculovirus expression vectors [26] have made the technique simpler and more rapid than expression using stably transformed mammalian cells; potentially, this will allow readier production of site-directed or natural mutant forms of LCAT recognized and cleaved by the cells, that correct pairing of the protein for a variety of structure-function studies.
